Related Experiment Videos
Lead nitrate and gadolinium chloride administration modify hepatocyte cell surfaces
P Pagliara1, A Chionna, E C Carlà
1Department of Biological and Environmental Science and Technology, University of Lecce, Via per Monteroni, 73100, Lecce, Italy.
Cell and Tissue Research
|April 10, 2003
Summary
Gadolinium chloride (GdCl(3)) pretreatment reduced lead nitrate (Pb(NO(3))(2))-induced liver damage in rats. GdCl(3) administration before Pb(NO(3))(2) mitigated hepatocyte cell surface alterations, suggesting a protective effect against heavy metal-induced liver injury.
Area of Science:
- Hepatology
- Toxicology
- Cell Biology
Background:
- Heavy metals like lead nitrate (Pb(NO(3))(2)) can induce significant liver damage, including hyperplasia and apoptosis.
- Gadolinium chloride (GdCl(3)) is known to affect parenchymal cell proliferation and Kupffer cells in the liver.
Purpose of the Study:
- To investigate the effects of Pb(NO(3))(2) and GdCl(3) on hepatocyte cell surface modifications.
- To determine if GdCl(3) administration prior to Pb(NO(3))(2) exposure can mitigate liver damage.
Main Methods:
- Rats were injected with Pb(NO(3))(2) or GdCl(3) alone, or GdCl(3) followed by Pb(NO(3))(2) 24 hours later.
- Hepatocytes were isolated at 1, 3, and 5 days post-treatment via enzymatic liver perfusion.
- Changes in phosphatidylserine (PS) expression, asialoglycoprotein receptors (ASGPRs), and sugar residues on hepatocyte surfaces were quantified alongside apoptosis and proliferation rates.
Main Results:
- Single Pb(NO(3))(2) injection induced liver hyperplasia and apoptosis, leading to cell surface alterations.
- GdCl(3) alone affected parenchymal cell proliferation and Kupffer cell populations.
- Pre-administration of GdCl(3) 24 hours before Pb(NO(3))(2) significantly reduced liver hyperplasia, apoptosis, and subsequent cell surface modifications.
Conclusions:
- Pb(NO(3))(2) and GdCl(3) induce distinct but significant changes in hepatocyte cell surface markers.
- GdCl(3) exhibits a protective effect, preventing or reducing the liver damage induced by Pb(NO(3))(2).
- This suggests GdCl(3) could be a potential therapeutic agent for mitigating heavy metal-induced liver injury.